|
Wed, 05/21/2025 - 01:03 |
URI College of Pharmacy researcher studies link between stroke and Alzheimers Disease |
University of R... |
|
Tue, 03/11/2025 - 14:05 |
Shrinking axonal spheroids may be a new approach for treating Alzheimer's disease. |
YaleUniversity |
|
Fri, 03/07/2025 - 17:26 |
NIH funding drives life-saving innovation and economic impact in Wisconsin. University, biomedical and industry leaders issue call to protect it. |
University of W... |
|
Mon, 02/10/2025 - 14:59 |
Early ovary removal linked to higher Alzheimers risk for some women |
UniversityofToronto |
|
Mon, 07/01/2024 - 17:16 |
Biden-Harris Administration Invests Over $200 Million to Help Primary Care Doctors, Nurses, and Other Health Care Providers Improve Care for Older Adults |
HHS |
|
Mon, 06/17/2024 - 11:54 |
New drug for Alzheimers disease wins FDA advisory committees approval |
University of M... |
|
Thu, 05/16/2024 - 23:40 |
Older American Indians may experience higher levels of cognitive impairment than previously thought |
NIH |
|
Fri, 03/01/2024 - 13:58 |
Poor spatial navigation could predict Alzheimers disease years before the onset of symptoms |
UniversityColle... |
|
Fri, 01/21/2022 - 14:04 |
California Institute for Regenerative Medicine and the Davos Alzheimers Collaborative Release a Statement of Interest to Advance Brain Research |
CIRM |
|
Wed, 12/22/2021 - 05:53 |
Japans First Committee on New Drugs of The Pharmaceutical Affairs and Food Sanitation Council Seeks Additional Data; Aducanumab Remains under Review |
EISAI |
|
Tue, 12/21/2021 - 09:47 |
Fifty Years of Funding Alzheimers Disease Research |
Gladstone Institutes |
|
Tue, 12/14/2021 - 03:38 |
Racial equity in Alzheimers research focus of $7 million in grants |
Washington Univ... |
|
Wed, 11/17/2021 - 16:12 |
Update on Regulatory Review of Aducanumab in the European Union |
EISAI |
|
Mon, 11/15/2021 - 12:54 |
Potential vaccine against Alzheimers show promise in mice |
Alzheimers Research |
|
Mon, 11/08/2021 - 23:09 |
DIAN-TU SELECTS LECANEMAB AS BACKGROUND ANTI-AMYLOID THERAPY IN CLINICAL TRIAL EVALUATING INVESTIGATIONAL THERAPY TARGETING TAU FOR DOMINANTLY INHERITED ALZHEIMER'S DISEASE |
EISAI |
|
Tue, 10/12/2021 - 19:17 |
Dialing up resilience against dementia |
Jackson Laboratory |
|
Wed, 09/29/2021 - 18:35 |
No increased dementia risk after hormone replacement therap |
Alzheimers Research |
|
Tue, 09/28/2021 - 00:14 |
More effective treatment of Alzheimers |
UppsalaUniversity |
|
Thu, 08/26/2021 - 08:28 |
Brain Tissue Inflammation Drives Alzheimers Disease |
UPMC |
|
Wed, 08/11/2021 - 14:40 |
Diabetes drug may reduce dementia risk, new study suggests |
Alzheimers Research |
|
Wed, 08/11/2021 - 07:08 |
Alliance for Aging Research Submits Comments on Coverage for Monoclonal Antibodies for Alzheimers Disease |
Alliance for Ag... |
|
Thu, 06/24/2021 - 08:18 |
EISAI AND BIOGEN INC. ANNOUNCE U.S. FDA GRANTS BREAKTHROUGH THERAPY DESIGNATION FOR LECANEMAB (BAN2401), AN ANTI-AMYLOID BETA PROTOFIBRIL ANTIBODY FOR THE TREATMENT OF ALZHEIMERS DISEASE |
EISAI |
|
Wed, 06/23/2021 - 20:03 |
EISAI AND BIOGEN INC. ANNOUNCE U.S. FDA GRANTS BREAKTHOUGH THERAPY DESIGNATION FOR LECANEMAB (BAN2401), AN ANTI-AMYLOID BETA PROTOFIBRIL ANTIBODY FOR THE TREATMENT OF ALZHEIMERS DISEASE |
EISAI |
|
Wed, 06/23/2021 - 07:01 |
More seniors may have undiagnosed dementia than previously thought |
University of M... |
|
Tue, 04/13/2021 - 16:43 |
Alzheimer's Association awards research grant to Jackson Laboratory scientists |
Jackson Laboratory |
